Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stem Cell Research

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    August 2018
  1. FUNATO M, Ozeki M, Suzuki A, Ishihara M, et al
    Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
    Anticancer Res. 2018;38:4691-4697.
    PubMed     Text format     Abstract available


  2. TOGASHI K, Okada M, Yamamoto M, Suzuki S, et al
    A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.
    Anticancer Res. 2018;38:4535-4542.
    PubMed     Text format     Abstract available


    July 2018
  3. CHANDIMALI N, Huynh DL, Jin WY, Kwon T, et al
    Combination Effects of Hispidin and Gemcitabine via Inhibition of Stemness in Pancreatic Cancer Stem Cells.
    Anticancer Res. 2018;38:3967-3975.
    PubMed     Text format     Abstract available


  4. MAIUTHED A, Chantarawong W, Chanvorachote P
    Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
    Anticancer Res. 2018;38:3797-3809.
    PubMed     Text format     Abstract available


    June 2018
  5. KOESSINGER D, Albrecht V, Faber F, Jaehnert I, et al
    ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells.
    Anticancer Res. 2018;38:3347-3355.
    PubMed     Text format     Abstract available


    May 2018
  6. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
    Effect of Tissue Factor on Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:2635-2642.
    PubMed     Text format     Abstract available


  7. NASSEREDDINE S, Alsubait S, Tabbara I
    Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
    Anticancer Res. 2018;38:2597-2605.
    PubMed     Text format     Abstract available


  8. KAWAMOTO M, Umebayashi M, Tanaka H, Koya N, et al
    Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
    Anticancer Res. 2018;38:2739-2748.
    PubMed     Text format     Abstract available


    April 2018
  9. TERASAKI M, Ogawa Y, Endo T, Maeda H, et al
    Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
    Anticancer Res. 2018;38:2169-2179.
    PubMed     Text format     Abstract available


  10. SANTORO R, Zanotto M, Carbone C, Piro G, et al
    MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
    Anticancer Res. 2018;38:1937-1946.
    PubMed     Text format     Abstract available


    March 2018
  11. KANEKO S, Sato C, Shiozawa N, Sato A, et al
    Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.
    Anticancer Res. 2018;38:1391-1399.
    PubMed     Text format     Abstract available


    February 2018
  12. KANG S, Oh SC, Min BW, Lee DH, et al
    Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:787-794.
    PubMed     Text format     Abstract available


    January 2018
  13. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Anticancer Res. 2018;38:313-320.
    PubMed     Text format     Abstract available


  14. LAPINSKA K, Faria G, McGonagle S, Macumber KM, et al
    Cancer Progenitor Cells: The Result of an Epigenetic Event?
    Anticancer Res. 2018;38:1-6.
    PubMed     Text format     Abstract available


    November 2017
  15. SANOMACHI T, Suzuki S, Kuramoto K, Takeda H, et al
    Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
    Anticancer Res. 2017;37:6177-6188.
    PubMed     Text format     Abstract available


    October 2017
  16. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Text format     Abstract available


  17. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Text format     Abstract available


    September 2017
  18. SAKABE T, Azumi J, Umekita Y, Toriguchi K, et al
    Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:4881-4888.
    PubMed     Text format     Abstract available


  19. JUNGBAUER F, Aderhold C, Birk R, Hoermann K, et al
    Communicate or Die - A Model for HPV+ and HPV- CSCs and Their Interactions with SDF-1alpha.
    Anticancer Res. 2017;37:4827-4836.
    PubMed     Text format     Abstract available


  20. GOMES JPA, Assoni AF, Pelatti M, Coatti G, et al
    Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
    Anticancer Res. 2017;37:4747-4758.
    PubMed     Text format     Abstract available


    August 2017
  21. URUSHIBARA S, Tsubota T, Asai R, Azumi J, et al
    WNT/beta-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil.
    Anticancer Res. 2017;37:4085-4091.
    PubMed     Text format     Abstract available


  22. LI Y, Wu J, Feng F, Men C, et al
    A Preclinical Study of Cell-seeded Tubularized Scaffolds Specially Secreting LL37 for Reconstruction of Long Urethral Defects.
    Anticancer Res. 2017;37:4295-4301.
    PubMed     Text format     Abstract available


    July 2017
  23. SETO K, Sakabe T, Itaba N, Azumi J, et al
    A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Anticancer Res. 2017;37:3569-3579.
    PubMed     Text format     Abstract available


  24. HAYASHI T, Yamashita T, Okada H, Oishi N, et al
    A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3397-3403.
    PubMed     Text format     Abstract available


  25. PAN XY, Tsai MH, Wuputra K, Ku CC, et al
    Application of Cancer Cell Reprogramming Technology to Human Cancer Research.
    Anticancer Res. 2017;37:3367-3377.
    PubMed     Text format     Abstract available


    June 2017
  26. ERCAN G, Karlitepe A, Ozpolat B
    Pancreatic Cancer Stem Cells and Therapeutic Approaches.
    Anticancer Res. 2017;37:2761-2775.
    PubMed     Text format     Abstract available


    May 2017
  27. MIYATA T, Oyama T, Yoshimatsu T, Higa H, et al
    The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
    Anticancer Res. 2017;37:2541-2547.
    PubMed     Text format     Abstract available


  28. DA CRUZ PAULA A, Lopes C
    Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.
    Anticancer Res. 2017;37:2173-2183.
    PubMed     Text format     Abstract available


    April 2017
  29. STOTZ M, Herzog SA, Pichler M, Smolle M, et al
    Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
    Anticancer Res. 2017;37:2011-2018.
    PubMed     Text format     Abstract available


  30. BRADY PC, Soiffer RJ, Ginsburg ES
    Continuation of a Levonorgestrel Intrauterine Device During Hematopoietic Stem Cell Transplant: A Case Report.
    Anticancer Res. 2017;37:1985-1987.
    PubMed     Text format     Abstract available


  31. DAS T, Nair RR, Green R, Padhee S, et al
    Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
    Anticancer Res. 2017;37:1655-1663.
    PubMed     Text format     Abstract available


  32. NASSEREDDINE S, Rafei H, Elbahesh E, Tabbara I, et al
    Acute Graft Versus Host Disease: A Comprehensive Review.
    Anticancer Res. 2017;37:1547-1555.
    PubMed     Text format     Abstract available


  33. OKU Y, Nishiya N, Tsuda K, Shibazaki M, et al
    Dynamic Phenotypic Transition of Breast Cancer Cells In Vitro Revealed by Self-floating Cell Culture.
    Anticancer Res. 2017;37:1793-1797.
    PubMed     Text format     Abstract available


    March 2017
  34. TAKEDA D, Hasegawa T, Ueha T, Iwata E, et al
    Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1075-1082.
    PubMed     Text format     Abstract available


    February 2017
  35. SIRIMANGKALAKITTI N, Chamni S, Suwanborirux K, Chanvorachote P, et al
    Renieramycin M Attenuates Cancer Stem Cell-like Phenotypes in H460 Lung Cancer Cells.
    Anticancer Res. 2017;37:615-621.
    PubMed     Text format     Abstract available


  36. TIAN J, Xiao H, Wu R, Cao Y, et al
    The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.
    Anticancer Res. 2017;37:547-553.
    PubMed     Text format     Abstract available


    January 2017

  37. Germline Stem Cells.
    Anticancer Res. 2017;37:368.
    PubMed     Text format    



  38. Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract.
    Anticancer Res. 2017;37:363-364.
    PubMed     Text format    



  39. Working with Stem Cells.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    



  40. Stem Cell Processing.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    



  41. Stem Cell Heterogeneity. Methods and Protocols.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    



  42. Cancer Stem Cells, 1st Edition. Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance.
    Anticancer Res. 2017;37:363.
    PubMed     Text format    


  43. IMAI T, Oue N, Sentani K, Sakamoto N, et al
    KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
    Anticancer Res. 2017;37:47-55.
    PubMed     Text format     Abstract available


    December 2016
  44. TSAI PH, Cheng CH, Lin CY, Huang YT, et al
    Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.
    Anticancer Res. 2016;36:6367-6380.
    PubMed     Text format     Abstract available


  45. TAKEDA H, Okada M, Suzuki S, Kuramoto K, et al
    Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.
    Anticancer Res. 2016;36:6311-6318.
    PubMed     Text format     Abstract available


    November 2016
  46. PIRES BR, DE Amorim IS, Souza LD, Rodrigues JA, et al
    Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Anticancer Res. 2016;36:5681-5691.
    PubMed     Text format     Abstract available


  47. CHANVORACHOTE P, Chamni S, Ninsontia C, Phiboonchaiyanan PP, et al
    Potential Anti-metastasis Natural Compounds for Lung Cancer.
    Anticancer Res. 2016;36:5707-5717.
    PubMed     Text format     Abstract available


    October 2016
  48. KARAS M, Steinerova K, Lysak D, Hrabetova M, et al
    Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission.
    Anticancer Res. 2016;36:5487-5498.
    PubMed     Text format     Abstract available


  49. SUZUKI S, Okada M, Kuramoto K, Takeda H, et al
    Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance.
    Anticancer Res. 2016;36:5153-5161.
    PubMed     Text format     Abstract available


  50. NAPOLETANO C, Bellati F, Ruscito I, Pernice M, et al
    Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells.
    Anticancer Res. 2016;36:5109-5116.
    PubMed     Text format     Abstract available


    August 2016

  51. Fetal Stem Cells in Regenerative Medicine. Principles and Translational Strategies.
    Anticancer Res. 2016;36:4374-5.
    PubMed     Text format    



  52. Mesenchymal Stem Cells. Methods and Protocols.
    Anticancer Res. 2016;36:4371.
    PubMed     Text format    


  53. HOWARD CB, McDowell R, Feleke K, Deer E, et al
    Chemotherapeutic Vulnerability of Triple-negative Breast Cancer Cell-derived Tumors to Pretreatment with Vernonia amygdalina Aqueous Extracts.
    Anticancer Res. 2016;36:3933-43.
    PubMed     Text format     Abstract available


    July 2016
  54. MUKOHYAMA J, Shimono Y, Yamashita K, Sumi Y, et al
    Effect of Xenotransplantation Site on MicroRNA Expression of Human Colon Cancer Stem Cells.
    Anticancer Res. 2016;36:3679-86.
    PubMed     Text format     Abstract available


  55. TASAKI T, Fujita M, Okuda T, Yoneshige A, et al
    MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme.
    Anticancer Res. 2016;36:3571-7.
    PubMed     Text format     Abstract available


  56. PYLVAS-EEROLA M, Liakka A, Puistola U, Koivunen J, et al
    Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-treated Patients with Ovarian Cancer.
    Anticancer Res. 2016;36:3425-31.
    PubMed     Text format     Abstract available


  57. SAKAUE M, Maeda K, Ohno S, Ito T, et al
    Screening for Identification of Personalized Food to Promote Adiponectin Secretion in Patients with Cancer.
    Anticancer Res. 2016;36:3673-7.
    PubMed     Text format     Abstract available


    February 2016
  58. YOSHIYAMA A, Morii T, Ohtsuka K, Ohnishi H, et al
    Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid.
    Anticancer Res. 2016;36:625-31.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: